Table 1.
Characteristics of Study Participants
| Characteristic | Summary Arm (n = 44), n (%) | Narrative Arm (n = 38), n (%) | p-value |
|---|---|---|---|
| Sex | 0.64 | ||
| Male | 27 (61) | 21 (55) | |
| Female | 15 (39) | 16 (45) | |
| Level of training | 0.81 | ||
| First year resident | 14 (32) | 8 (21) | |
| Second year resident | 7 (16) | 7 (18) | |
| Third year resident | 9 (20) | 10 (26) | |
| Fourth year resident | 9 (20) | 7 (18) | |
| Attending or fellow | 5 (11) | 6 (16) | |
| Median (IQR) age (yr) | 29 (28–31) | 29 (28–31) | 0.67 |
| Prior knowledge of PDMPs (self-reported) | 0.67 | ||
| No knowledge | 10 (23) | 7 (18) | |
| Some knowledge | 23 (52) | 18 (47) | |
| Moderate knowledge | 10 (23) | 12 (32) | |
| In-depth knowledge | 1 (2) | 1 (3) | |
| Training program | 0.62 | ||
| Program 1 | 13 (30) | 7 (18) | |
| Program 2 | 7 (16) | 9 (24) | |
| Program 3 | 6 (14) | 6 (16) | |
| Program 4 | 5 (11) | 5 (13) | |
| Program 5 | 3 (7) | 6 (16) | |
| Program 6 | 5 (11) | 2 (5) | |
| Other | 4 (9) | 2 (5) |
N = 82.
PDMP = prescription drug monitoring program.